Integral Health Asset Management’s AbbVie ABBV Stock Holding History

Integral Health Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-40,000	Closed	-$7.42M	–	77
2025 Q2	$7.42M	Sell	40,000 -20,000	-33%	-$3.72M	0.68%	43
2025 Q1	$12.6M	Buy	+60,000	New	+$11.7M	1.34%	23
2024 Q2	–	Sell	-135,000	Closed	-$24.6M	–	74
2024 Q1	$24.6M	Sell	135,000 -35,000	-21%	-$6.03M	2.28%	11
2023 Q4	$26.3M	Buy	+170,000	New	+$24.8M	3.59%	4
2023 Q3	–	Sell	-100,000	Closed	-$13.5M	–	66
2023 Q2	$13.5M	Buy	100,000 +19,000	+23%	+$2.79M	1.67%	18
2023 Q1	$12.9M	Buy	81,000 +31,000	+62%	+$4.74M	2.6%	6
2022 Q4	$8.08M	Buy	+50,000	New	+$7.67M	1.7%	27
2022 Q1	–	Sell	-50,000	Closed	-$6.77M	–	72
2021 Q4	$6.77M	Buy	50,000 +15,000	+43%	+$1.77M	1.87%	21
2021 Q3	$3.77M	Buy	+35,000	New	+$4M	1.09%	37
2021 Q1	–	Sell	-70,000	Closed	-$7.5M	–	70
2020 Q4	$7.5M	Buy	+70,000	New	+$6.73M	2.23%	19
2020 Q3	–	Sell	-25,000	Closed	-$2.46M	–	73
2020 Q2	$2.46M	Buy	+25,000	New	+$2.2M	0.74%	48
2020 Q1	–	Sell	-95,000	Closed	-$8.41M	–	53
2019 Q4	$8.41M	Buy	+95,000	New	+$7.89M	3.28%	14

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Integral Health Asset Management's ABBV Position: Q3 2025 in Review

Integral Health Asset Management sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 40,000 shares — an estimated $7.42M sold.

Integral Health Asset Management first reported a position in ABBV in Q4 2019 and held it in 12 quarters. The position peaked at $26.3M in Q4 2023. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

Integral Health Asset Management reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
Integral Health Asset Management sold 40,000 AbbVie shares in Q3 2025, an estimated $7.42M.
Integral Health Asset Management first reported a position in AbbVie in Q4 2019 and held it in 12 quarters.
Integral Health Asset Management's AbbVie position peaked at $26.3M in Q4 2023.
3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Integral Health Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.